Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-12-13

FDA Approved: PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for a generic Perphenazine and Amitriptyline Hydrochloride product manufactured by Mylan Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE (perphenazine and amitriptyline hydrochloride)

Snippet

SUPPL AP for PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE (PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE)